Charles Abraham

[Charles Abraham @SaniTimer]

@MFHoz I love all the charts and bearish posts coming in after 8 months of selling when all the fear is priced in. Means it's time to rally before cooling off in Sept / Oct. Lookin good.

[Charles Abraham @SaniTimer]

@POTUS Where was Biden during the pandemic when Zoom stock qudrulpled , tech stocks made billions, and the top two tech companies made more money than the whole energy sector is making today, COMBINED.

Why no tweet about free zoom for everybody or tech needed to work from home at cost?

[Charles Abraham @SaniTimer]

@ryancohen The solution is for Main Street to start learning and playing the Wall Street game.

I've run my own small business for 10 years and do well, but have a corporate investment account where investment profits help me keep prices lower for my customers and run my business better.

[Charles Abraham @SaniTimer]

@zerohedge It's simple, it's going up bc everybody loaded puts & thinks it's going down.

Remember, smart money is doing the opposite of retail. Look at the replies... "bear market rally, lower coming"

Big money already sold & shorted, they are buying into retail selling here.

[Charles Abraham @SaniTimer]

@JavierBlas When you bite the hand that feeds you and then wonder why that hand gets "sensitive" lol

[Charles Abraham @SaniTimer]

@JavierBlas @axios It's absurd.

US Govt 2020: We are going green energy! Oil & Gas, we are coming for you!

Oil & Gas: Very well, no need to invest in expansion if nobody cares and it's going green.

US Govt 2022: The greedy Oil & Gas bastards won't drill!

Oil & Gas : Make up your mind.

[Charles Abraham @SaniTimer]

@JavierBlas It's all lipservice. The reality in the UK is that 46% of fuel prices go into the government's pocket via taxes. Fuel companies don't get that money, consumers don't get that money back, UK govt gets it and is loving every minute of it. No motivation to actually stop it.

[Charles Abraham @SaniTimer]

@IPC_Amy @WalsallHcareNHS @LisaRuthCarroll @whytecm @stefano_oggiano @IPCWalsall Very nice! Patient safety comes first. Let me know if you want to take aim at improving hand washing compliance!

[Charles Abraham @SaniTimer]

@EvonneTCurran @emrsa15 While hand hygiene, PROPER hand hygiene, is a must... airborne contamination is a different animal all together and quite eye opening.

[Charles Abraham @SaniTimer]

@stefano_oggiano @WalsallHcareNHS @IPCWalsall @IPC_Amy Congrats! Let me know if hand hygiene compliance is on your hit list!

[Charles Abraham @SaniTimer]

What if Shark Tank turned down an amazing product because it's more geared for B2B sales than B2C?

Patented Hand Washing Timer for food service businesses with Univ backed study results.

Take a flier on a proven winner?

@robertherjavec

[Charles Abraham @SaniTimer]

What if Shark Tank turned down an amazing product because it's more geared for B2B sales than B2C?

Patented Hand Washing Timer for food service businesses with Univ backed study results.

Help with retail distribution?
@LoriGreiner

[Charles Abraham @SaniTimer]

What if Shark Tank turned down an amazing product because it's more geared for B2B sales than B2C?

Patented Hand Washing Timer for food service businesses with Univ backed study results.

Shot clock for hand washing? @mcuban

[Charles Abraham @SaniTimer]

What if Shark Tank turned down an amazing product because it's more geared for B2B sales than B2C?

Patented Hand Washing Timer for food service businesses with Univ backed study results.

Royalty deal? @kevinolearytv

[Charles Abraham @SaniTimer]

@sapphir70886367 @Biohazard3737 If you care about your followers or the data you are posting, don't cherry pick information to prove a pre determined personal stance on a stock, be objective.

The newest data shows 86% efficacy as the drug has time to really take course in a patient's system. Use accurate data

[Charles Abraham @SaniTimer]

@AYoncology @DickMedChem @reco_plasmid who knows nothing about therapeutic value in relation to saving dying assets and reinvigorating them versus just focusing on the monotherapy portion of things being blind to the rest. The company will prove my point for me soon enough.

[Charles Abraham @SaniTimer]

@AYoncology @DickMedChem @reco_plasmid combo, they would effectively extend their asset into another decade of usefulness and bringing in multibillions in revenues. Not to mention ONCT is the furthest along in trials and the closest to approval of any ROR1 signaling therapy. So I couldn't care less if an investor